Antimicrobial resistance
Antimicrobial resistance (AMR) arises when microorganisms develop the ability to survive exposure to antimicrobial agents, rendering standard treatments less effective (WHO, 2024).
Recognized as a critical global health challenge, AMR profoundly impacts patient outcomes, strains healthcare systems, and threatens economic stability worldwide.
Get the evidence to make a difference.
We know time is limited, but staying current on the latest impactful research, trials, and expert insights is essential. From AMR to diagnostic stewardship, these findings are highly relevant and impactful. These evidence summaries give you a concentrated, decision-ready view of complex topics from sepsis to diagnostic stewardship – highlighting what matters, what’s changing and what to do about it.
Evidence summary
This evidence summary brings together recent research on antimicrobial resistance, providing a clear and practical overview of resistance patterns, global drivers, and ongoing diagnostic and therapeutic challenges.
It translates these insights into actionable guidance, helping healthcare professionals strengthen stewardship efforts, enhance surveillance and infection prevention, and make more informed decisions to improve patient outcomes.
Enhanced with Dynamic Intelligence from BD Synapsys™
BD Synapsys™ connects your microbiology workflow from specimen receipt, to ID/AST, and reporting into a single intelligent ecosystem. It is designed to help optimize processes, reduce variability, and improve decision making.
You are not powerless.
The bleak statistics on sepsis mortality rates and evolving AMR can make it seem like healthcare institutions are losing the battle against pathogens. But labs are in a unique position to help counter these complex threats if they have access to fast and accurate microbiology data. As your partner, our Integrated Microbiology Ecosystem can help by connecting our microbiology instruments with BD Synapsys™ laboratory.
BD Synapsys™ Informatics Solution
Creating an Integrated Microbiology Ecosystem.
BD Synapsys™ turns complex clinical laboratory data into timely, actionable insights, helping to enhance nearly every aspect of operations in the lab and in the reporting of results.
BD BACTEC™ FXI Culture System
Introducing confidence for the fight back.
BD BACTEC™ FXI Culture System is our next-generation blood culture system, combining advanced automation, scalable capacity, and first-of-it's-kind gravimetric individual blood volume measurement.
BD BACTEC™ FX
Here for the fight back.
BD BACTEC™ FX is our legacy system, helping clinical microbiology laboratories deliver trusted blood culture testing when every result matters.
BD Phoenix™ M50 Automated Microbiology System
Strengthen your defense.
BD Phoenix™ M50 detects what others might miss. Advanced detection algorithm helps ensure accurate MIC readings – even when resistance takes time to emerge.
BD Kiestra™ Laboratory Automation Solutions
BD Kiestra™ Laboratory Automation Solutions give today's busy teams time to act. At a time when manual microbiology labs are under growing pressure with increasing sample volumes, and staffing pressures.
BD Diagnostic Solutions is Now Waters Advanced Diagnostics
BD Diagnostic Solutions and Biosciences have combined with Waters Corporation to create a life sciences and diagnostics leader driven by innovation and a relentless commitment to our customers.
As we begin our new journey as part of Waters, there will be no immediate changes in how we serve you. The way you order your products and services and how you process payment for them will not change. Your points of contact for sales, customer service, technical service and support or clinical services will remain the same.
